Wegovy 0.5 ml: what the volume on your pen tells you (and what it doesn't)

Picture the moment the box arrives: what 0.5 ml actually refers to

Your Wegovy starter kit arrives in a plain, unbranded box, DPD tracking updates on your phone, nothing on the packaging to broadcast what's inside. When you open the pen for the first time and look at the scale on the side, you'll see the 0.5 ml mark. Many people at this point assume they should be drawing up to that line, or that it indicates a specific strength. It doesn't mean either of those things.

The Wegovy pre-filled pen is not a syringe you fill yourself. The 0.5 ml is already inside, pre-measured, pre-sealed. It simply describes the total volume of liquid the pen contains and ejects when you press the button against your skin. The pen does the work; that figure on the barrel is a manufacturing specification, not an instruction.

What actually determines the potency of your injection is the concentration of semaglutide dissolved in that 0.5 ml. At the 0.25 mg step, the concentration is low. By the time a prescriber moves someone to the 2.4 mg maintenance dose, the concentration is considerably higher, yet the pen still delivers exactly 0.5 ml. The full Wegovy dose schedule explains each step in the titration pathway and what to expect at each stage.

The NHS semaglutide medicines page is a reliable starting point for understanding how the injection works and what each pen contains.

Why the same volume holds different strengths, and what that means for your titration

This is the part patients tell us they wish someone had explained earlier. Across the Wegovy dose ladder, the injected volume stays fixed at 0.5 ml while the concentration of active ingredient rises at each step. That design choice is deliberate: it makes the pen simpler to use and keeps the administration technique identical from your very first 0.25 mg pen to the highest dose.

The licensed titration schedule for the injection starts at 0.25 mg for the first four weeks, then moves through 0.5 mg, 1.0 mg, and 1.7 mg before reaching the standard 2.4 mg maintenance dose, each step taken roughly four weeks apart, as directed by a prescriber. In January 2026 the MHRA also approved a 7.2 mg dose option for adults with obesity. Through every single one of those steps, the injected volume is 0.5 ml. Only the concentration changes.

This matters practically because some people try to compare how full their current pen looks against a previous one, or assume a pen that seems less full must be a lower dose. That comparison doesn't hold. A pen at 2.4 mg and a pen at 0.25 mg look functionally the same. For more on the specific strengths and how the 0.5 ml pens relate to dose names, this page on the 0.5 mg pen covers how that particular step in the schedule is labelled and dispensed.

Never try to adjust the amount injected or estimate your dose visually. The pen is single-dose; press the button, hold for the count your leaflet specifies, and withdraw. The prescriber's written instructions and your Patient Information Leaflet govern everything about timing and administration, not the volume marking.

Which 0.5 ml Wegovy pen do you actually have?

Because every strength comes in a 0.5 ml pen, it can feel confusing when different pages reference numbers like 0.25 mg/0.5 ml, 0.5 mg/0.5 ml, 1.0 mg/0.5 ml, or 1.7 mg/0.5 ml. The naming convention used on official UK pharmacy labelling puts both figures together: the first is the dose strength in milligrams of semaglutide, the second is always the 0.5 ml volume. So a pen labelled 1 mg/0.5 ml contains 1 mg of semaglutide dissolved in 0.5 ml of fluid.

If you have been prescribed the 0.25 mg step, the 0.25 mg/0.5 ml pen guide covers what to expect from that specific pen. For the 0.5 mg step, the 0.5 mg/0.5 ml pen page has the relevant detail. The step up from there (the 1 mg/0.5 ml pen) is a common point at which patients have questions about the jump in concentration.

Checking the label your pen arrived with, and matching it against what your prescriber wrote in your instructions, is always the right move if you're uncertain which pen you're holding. If anything on the label doesn't match what was prescribed, contact your prescribing team before injecting.

Cost, NHS access, and what a private route looks like

Wegovy is a Prescription-Only Medicine, which means the only legal route to it in the UK is a prescription from a qualified prescriber after a clinical assessment. For many people that question quickly becomes a practical one about cost and access. Wegovy pricing in the UK explains the landscape honestly, including what private treatment typically costs and what that price should include. On the NHS, Wegovy for weight management is currently available through specialist weight management services under NICE guidance, waiting lists are commonly long, and the criteria are specific.

A private consultation through a regulated online pharmacy is the route people take when they don't meet NHS criteria or can't wait. The weight-loss treatments page walks through how that process works at nume, from a free consultation reviewed the same day by a real prescriber through to next-working-day delivery. The weight-loss overview compares the medicines currently available if you're still deciding which treatment to ask about. For general questions about how the service runs, the FAQs cover the practicalities. If you'd like to check who reviews consultations clinically, our clinical team profile is there.

The NICE appraisal of semaglutide for weight management (TA875) sets out the formal clinical criteria, including the comorbidity and BMI thresholds that apply on the NHS route. Private eligibility is assessed by the prescriber on a case-by-case basis and differs from those NHS-specific thresholds.

Speak to our prescribers if you have questions about Wegovy and whether it's right for your situation, a free consultation is the place to start.